Friedl, T. W. P., Fehm, T., Müller, V., Lichtenegger, W., Blohmer, J., Lorenz, R., . . . Rack, B. (2021). Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment: A Phase 3 Randomized Clinical Trial. JAMA Oncol.
Chicago-стиль цитированияFriedl, Thomas W. P., et al. "Prognosis of Patients With Early Breast Cancer Receiving 5 Years Vs 2 Years of Adjuvant Bisphosphonate Treatment: A Phase 3 Randomized Clinical Trial." JAMA Oncol 2021.
MLA-цитированиеFriedl, Thomas W. P., et al. "Prognosis of Patients With Early Breast Cancer Receiving 5 Years Vs 2 Years of Adjuvant Bisphosphonate Treatment: A Phase 3 Randomized Clinical Trial." JAMA Oncol 2021.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.